ReShape Lifesciences Inc. |
10%+ Owner |
Common Stock |
7.22M |
$39.6M |
$5.48 |
Jun 28, 2021 |
Direct |
ReShape Lifesciences Inc. |
10%+ Owner |
Common Stock |
7.22M |
$39.6M |
$5.48 |
Jun 28, 2021 |
Indirect |
EYEGATE PHARMACEUTICALS INC |
10%+ Owner |
Common Stock |
785K |
$3.01M |
$3.83 |
Aug 2, 2021 |
Indirect |
AYTU BIOPHARMA, INC |
Director |
Common Stock |
1.34M |
$2.51M |
$1.87 |
Mar 29, 2021 |
Direct |
AYTU BIOPHARMA, INC |
Director |
Common Stock |
1.34M |
$2.51M |
$1.87 |
Mar 29, 2021 |
Indirect |
Avalo Therapeutics, Inc. |
10%+ Owner |
Common Stock |
731K |
$380K |
$0.52 |
Jun 27, 2023 |
Indirect |
Avalo Therapeutics, Inc. |
10%+ Owner |
Common Stock |
34.4K |
$17.9K |
$0.52 |
Jun 26, 2023 |
Direct |
TENAX THERAPEUTICS, INC. |
Director |
Pre-Funded Common Stock Purchase Warrants |
10.6M |
|
|
May 18, 2022 |
Indirect |
TENAX THERAPEUTICS, INC. |
Director |
Series C Common Stock Purchase Warrants |
10.6M |
|
|
May 18, 2022 |
Indirect |
TENAX THERAPEUTICS, INC. |
Director |
Warrant (right to buy) |
4.77M |
|
|
May 18, 2022 |
Indirect |
TENAX THERAPEUTICS, INC. |
Director |
Series B Common Stock Purchase Warrants |
3.18M |
|
|
May 18, 2022 |
Indirect |
TENAX THERAPEUTICS, INC. |
Director |
Common Stock Purchase Warrants |
2.07M |
|
|
May 18, 2022 |
Indirect |
EYEGATE PHARMACEUTICALS INC |
10%+ Owner |
Series C Convertible Preferred Stock |
0 |
|
|
Jul 27, 2021 |
Indirect |
ReShape Lifesciences Inc. |
10%+ Owner |
Series A Warrants |
0 |
|
|
Jun 28, 2021 |
Direct |
ReShape Lifesciences Inc. |
10%+ Owner |
Series A Warrants |
0 |
|
|
Jun 28, 2021 |
Indirect |
ReShape Lifesciences Inc. |
10%+ Owner |
Series E Warrants |
0 |
|
|
Jun 28, 2021 |
Direct |
ReShape Lifesciences Inc. |
10%+ Owner |
Series E Warrants |
0 |
|
|
Jun 28, 2021 |
Indirect |
ReShape Lifesciences Inc. |
10%+ Owner |
Series G Warrants |
0 |
|
|
Jun 28, 2021 |
Direct |
ReShape Lifesciences Inc. |
10%+ Owner |
Series G Warrants |
0 |
|
|
Jun 28, 2021 |
Indirect |
ReShape Lifesciences Inc. |
10%+ Owner |
Warrant |
0 |
|
|
Jun 28, 2021 |
Direct |
ReShape Lifesciences Inc. |
10%+ Owner |
Warrant |
0 |
|
|
Jun 28, 2021 |
Indirect |
ReShape Weightloss Inc. |
10%+ Owner |
Common Stock |
0 |
|
|
Jun 15, 2021 |
Direct |
ReShape Weightloss Inc. |
10%+ Owner |
Common Stock |
0 |
|
|
Jun 15, 2021 |
Indirect |
ReShape Weightloss Inc. |
10%+ Owner |
Series A Warrants |
0 |
|
|
Jun 15, 2021 |
Direct |
ReShape Weightloss Inc. |
10%+ Owner |
Series A Warrants |
0 |
|
|
Jun 15, 2021 |
Indirect |
ReShape Weightloss Inc. |
10%+ Owner |
Series E Warrants |
0 |
|
|
Jun 15, 2021 |
Direct |
ReShape Weightloss Inc. |
10%+ Owner |
Series E Warrants |
0 |
|
|
Jun 15, 2021 |
Indirect |
ReShape Weightloss Inc. |
10%+ Owner |
Series G Warrants |
0 |
|
|
Jun 15, 2021 |
Direct |
ReShape Weightloss Inc. |
10%+ Owner |
Series G Warrants |
0 |
|
|
Jun 15, 2021 |
Indirect |
ReShape Weightloss Inc. |
10%+ Owner |
Warrant |
0 |
|
|
Jun 15, 2021 |
Direct |
ReShape Weightloss Inc. |
10%+ Owner |
Warrant |
0 |
|
|
Jun 15, 2021 |
Indirect |